M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant, 200 U/uL
Research
Online Inquiry

M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant, 200 U/uL

Cat.No: IEC-HMM-0078 Datasheet

Quantities:
- +
Product Details Related Products
Product Name M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant, 200 U/uL
Catalog No. IEC-HMM-0078
Description Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase engineered with point mutations in the RNase H domain that eliminate intrinsic RNase H activity while retaining full RNA-dependent and DNA-dependent DNA polymerase activity. The elimination of RNase H activity prevents degradation of the RNA template during first-strand cDNA synthesis, resulting in significantly longer cDNA products (up to 12 kb) and higher full-length cDNA yields compared to wild-type M-MLV RT. The enzyme is supplied at 200 U/uL and includes 5x reaction buffer and 0.1 M DTT. It is the preferred enzyme for cDNA synthesis for RT-PCR, qRT-PCR, cDNA library construction, 3'- and 5'-RACE, and RNA-seq library preparation requiring long transcripts.
Intended Use First-strand cDNA synthesis from total RNA or poly(A)+ RNA for downstream applications including two-step RT-PCR, quantitative real-time RT-PCR (qRT-PCR), cDNA library construction, rapid amplification of cDNA ends (RACE), RNA sequencing (RNA-seq) library preparation, and probe synthesis for microarray and northern blot hybridization.
Principle / Technology Engineered M-MLV reverse transcriptase catalyzes RNA-dependent DNA synthesis using an oligo(dT) primer, random hexamers, or gene-specific primer. The enzyme synthesizes a complementary DNA strand in the 5'->3' direction using RNA as template. The point mutations (D524N, etc.) in the RNase H domain abolish Mg2+-dependent hydrolysis of the RNA strand in RNA-DNA hybrids, preventing premature termination and 3' end degradation of the cDNA, leading to longer cDNA products and higher representation of 5' ends of long mRNAs.
Detection Method Mix total RNA (1 pg-5 ug) or poly(A)+ RNA (1 pg-500 ng) with primer (oligo(dT)18 50 uM or random hexamers 50 ng/uL or gene-specific primer 2 pmol), dNTPs (0.5 mM each), 1x RT Buffer, 0.01 M DTT, 200 U M-MLV RT (RNase H-); incubate 50-60 min at 42 C (or 50 C for GC-rich templates with high secondary structure); inactivate 15 min at 70 C.
Sample Type Total RNA (1 pg-5 ug in up to 10 uL), poly(A)+ mRNA (1 pg-500 ng), in vitro transcribed RNA, viral genomic RNA.
Performance Range / Specifications cDNA synthesis length: up to 12 kb (first-strand); optimal synthesis 42 C (range 37-55 C); incorporation efficiency: >80% of RNA template converted to full-length cDNA for transcripts up to 5 kb; linear dynamic range: 1 pg-5 ug total RNA input.
Sensitivity / LOD First-strand cDNA detectable from as little as 1 pg total RNA (approximately 1 cell equivalent) by qPCR of housekeeping gene (GAPDH, beta-actin); linear Cq vs log(input) over six orders of magnitude.
Specificity RNase H- mutant specifically lacks RNase H activity while maintaining polymerase activity; no detectable RNase H activity in standard assay; sequence-nonspecific cDNA synthesis, primers determine specificity of initiation; no endogenous RNase, DNase, or nicking activity.
Reaction Conditions / Protocol cDNA synthesis: 50-60 min at 42 C (optimal) or up to 55 C for GC-rich templates; heat inactivation: 15 min at 70 C; cDNA can be used directly for PCR (1-2 uL per 25 uL PCR reaction) or stored at -20 C.
Components / Formulation M-MLV Reverse Transcriptase (RNase H-, 200 U/uL, in 20 mM Tris-HCl pH 7.5, 200 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.01% NP-40, 50% glycerol), 5x RT Buffer (250 mM Tris-HCl pH 8.3 at 25 C, 375 mM KCl, 15 mM MgCl2), 0.1 M DTT, Protocol.
Storage Conditions Store at -20 C; stable at 2-8 C for up to 1 month; avoid repeated freeze-thaw cycles.
Shelf Life 24 months from date of manufacture at -20 C.
Package Specifications 10,000 U (50 uL), 20,000 U (100 uL), 100,000 U (500 uL).
Product Form Liquid; 200 U/uL in 50% glycerol storage buffer.
Quality Control Each lot tested: no detectable RNase H activity (assay with [3H]-poly(A)-poly(dT) substrate); no detectable non-specific endonuclease or exonuclease activity; no detectable RNase contamination; full-length cDNA synthesis from 5 kb RNA transcript confirmed by agarose gel; functional qRT-PCR sensitivity down to 1 pg total RNA; no PCR inhibitors carried through.
Key Features RNase H minus for longer cDNA (up to 12 kb); high sensitivity (1 pg RNA); functional at 37-55 C; active with oligo(dT), random hexamers, or gene-specific primers; no RNase H degradation of template RNA during synthesis.
Purity >95% pure by SDS-PAGE; no detectable RNase H, RNase, DNase, endonuclease, or exonuclease activities; host genomic DNA <10 copies per unit.
Concentration 200 U/uL (1 U = amount incorporating 1 nmol dTMP into acid-insoluble product in 10 min at 37 C using poly(A)-oligo(dT)12-18 as template-primer).
Activity / Unit Definition Specific activity: >=50,000 U/mg protein; RNase H activity: not detectable (assay limit <0.01 U RNase H per 200 U RT).
Molecular Weight Approximately 75 kDa (monomer).
Source / Origin Recombinant M-MLV reverse transcriptase with point mutations in RNase H domain (D524N, etc.) expressed in E. coli; purified by multiple chromatography steps including affinity, ion exchange, and size exclusion; no animal-derived components.
pH Range / Optimal pH Optimal pH 8.3 at 25 C (Tris-HCl); active range pH 7.5-9.0; 5x RT Buffer pH 8.3 at 25 C.
Shipping Conditions Cold pack or dry ice; stable at ambient for up to 3 days during transit.
Expiration Date / Stability 24 months at -20 C; 1 month at 2-8 C; quality retained after 15 freeze-thaw cycles.
Regulatory / Compliance For research use only; not for diagnostic or therapeutic use. ISO 9001 certified manufacturing.
Compatibility cDNA product compatible with all standard Taq and high-fidelity DNA polymerases for downstream PCR; compatible with SYBR Green and probe-based qPCR; cDNA may be purified by column or ethanol precipitation if buffer incompatibility is suspected. RNA template should be of high quality (RIN >=7 for best full-length synthesis). Inclusion of RNase inhibitor (e.g., RNasin) is recommended for long-term incubations or when working with low-abundance transcripts.
Recommended Buffer System 5x RT Buffer: 250 mM Tris-HCl pH 8.3, 375 mM KCl, 15 mM MgCl2; enzyme storage: 20 mM Tris-HCl pH 7.5, 200 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.01% NP-40, 50% glycerol.
Application Notes / Precautions For GC-rich RNA templates with high secondary structure, increase reaction temperature to 50-55 C using gene-specific primers (oligo(dT) and random hexamers are less efficient at elevated temperatures). For long transcripts (>5 kb), use gene-specific primers and incubate at 42 C for 60-90 min. Include a no-RT control reaction (omit reverse transcriptase) for each RNA sample to detect genomic DNA contamination in downstream PCR. For qRT-PCR, dilute cDNA 1:5 to 1:20 in nuclease-free water before use. To preserve RNA, add RNase inhibitor (1 U/uL final) to all RT reactions. Store cDNA at -20 C (short term) or -80 C (long term).
Batch-to-Batch Consistency cDNA yield from 1 ug HeLa total RNA within +/-20% of reference lot (GAPDH qPCR Cq); no RNase H activity detected for any lot; full-length cDNA synthesis confirmed for 5 kb control RNA.

For research use only, not for clinical use.

0
0

There is no product in your cart.